New strategies for the microencapsulation of tetanus vaccine

Journal of Microencapsulation

Volumn 15, Issue 3, 1998, Pages 299-318

  Schwendeman, Steven P ^a,c   Tobío, María ^a,b   Joworowicz, Monica ^a   Alonso, María José ^b   Langer, Robert ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Microencapsulation; Protein stability; Tetanus toxoid; Vaccine delivery

Indexed keywords

DEXTRAN; GELATIN; GLUTAMATE SODIUM; MACROGOL; POLYGLACTIN; TETANUS TOXOID;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG COATING; DRUG STABILITY; EXTRACTION; MICROENCAPSULATION; TECHNIQUE;

EID: 0031941871     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.3109/02652049809006859     Document Type: Article

References (44)

1. AGUADO, M. T., and LAMBERT, P. H., 1992, Controlled release vaccine-biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles. Immunobiology, 184, 113-125.
2. ALONSO, M. J., GUPTA, R. K., MIN, C., SIBER, G. R., and LANGER, R., 1994, Microspheres as controlled-release tetanus toxoid delivery systems. Vaccine, 12, 299-306.
3. ALONSO, M. J., VILLAMAYOR, B., TOBIO, M., SCHWENDEMAN, S. P., GUPTA, R. K., SIBER, G., and LANGER, R., 1996, Innovative approaches for the stabilization and controlled release of tetanus vaccine from polyester microspheres. Proceedings of the International Symposium on Controlled Release of Bioactive Materials, 23, 825-826.
4. ANDRADE, J. D., and HLADY, V., 1985, Protein adsorption and materials biocompatibility: A tutorial review and suggested hypotheses. Advances in Polymer Science, 79, 1-63.
5. BURKE, P. A., GRIFFIN, R. G., and KLIBANOV, A. M., 1992, Solid-state NMR assessment of enzyme active center structure under nonaqueous conditions. Journal of Biological Chemistry, 267, 20057-20064.
6. CARPENTER, J. F., PRESTRELSKI, S. J., and ARAKAWA, T., 1993, Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. Archives of Biochemistry & Biophysics, 303, 456-464.
7. COSTANTINO, H. R., LANGER, R., and KLIBANOV, A. M., 1994a, Moisture-induced aggregation of lyophilized insulin. Pharmaceutical Research, 11, 21-29.
8. COSTANTINO, H. R., LANGER, R., and KLIBANOV, A. M., 1994b, Solid-phase aggregation of proteins under pharmaceutically relevant conditions. Journal of Pharmaceutical Sciences, 83, 1662-1669.
9. COSTANTINO, H. R., LANGER, R., and KLIBANOV, A., 1995, Aggregation of a lyophilized pharmaceutical protein, recombinant human albumin: Effect of moisture and stabilization by excipients. Bio/Technology, 13, 493-496.
10. COSTANTINO, H. R., SCHWENDEMAN, S. P., GRIEBENOW, K. KLIBANOV, A. M., and LANGER, R., 1996, On the secondary structure and aggregation of lyophilized tetanus toxoid. Journal of Pharmaceutical Sciences 85, 1290-1293.
11. DABULIS, K., and KLIBANOV, A. M., 1993, Dramatic enhancement of enzymatic activity in organic solvents by lyoprotectants. Biotechnology and Bioengineering, 41, 556-571.
12. GOMBOTZ, W. R., 1990, Process for producing small particles of biologically active molecules. International Publication Number WO 90/13285.
13. GREENSPAN, L., 1977, Humidity fixed points of binary saturated aqueous solutions. Journal of Research, National Bureau of Standards, 81A, 89-96.
14. GUPTA, R. K., SIBER, G. R., ALONSO, M. J., and LANGER, R., 1993, Development of a single-dose tetanus toxoid based on controlled release from biodegradable and biocompatible polyester microspheres. In Vaccines 93, edited by F. Brown, R. Chanock, H. Ginsberg, and R. Lerner (Cold Spring Harbor: Cold Spring Harbor Laboratory Press), pp. 391-396.
15. HAGEMAN, M. J., 1992, Water sorption and solid-state stability of proteins. In Stability of Protein Pharmaceuticals. Part A. Chemical and Physical Pathways of Protein Degradation, edited by T. J. Ahern, and M. C. Manning (New York: Plenum Press), pp. 273-309.
16. HERRLINGER, M., 1994, In vitro polymerabbau un wirksttofffreigabe von poly-DL-laktidformlingen. PhD Thesis, University of Heildelberg.
17. HUTCHINSON, F. G., and FURR, B. J. A., 1990, Biodegradable polymer systems for the sustained release of polypeptides. Journal of Controlled Release, 13, 279-294.
18. LEE, L., and LEE, J., 1990, Thermal stability of proteins in the presence of poly(ethylene glycols). Biochemistry, 26, 7813-7819.
19. LI, S., GARREAU, H., and VERT, M., 1990a, Structure-property relationships in the case of the degradation of massive aliphatic poly-(α-hydroxy acids) in aqueous media, Part 1: Poly(DL-lactic acid). Journal of Material Science, Materia Medica, 1, 123-130.
20. LI, S. M., GARREAU, H., and VERT, M., 1990b, Structure-property relationships in the case of the degradation of massive aliphatic poly-(α-hydroxy acids) in aqueous media, Part 2: Degradation of lactide-glycolide copolymers: PLA37.5GA25 and PLA75GA25. Journal of Material Science, Materia Medica, 1, 131-139.
21. LIU, W. R., LANGER, R., and KLIBANOV, A. M, 1991, Moisture-induced aggregation of lyophilized proteins in the solid state. Biotechnology and Bioengineering, 37, 177-184.
22. LUSOW, A. R., AUADO, M. T., DEI GUIDICI, G., and LAMBERT, P. H., 1990, Towards vaccine optimization. Immunology Letters, 25, 255.
23. MASOOD, H., WHITE, J. L., and HEM, S. L., 1994, Relationship between protein adsorptive capacity and the X-ray diffraction pattern of aluminium hydroxide adjuvants. Vaccine, 12, 187-189.
24. OGAWA, Y., OKADA, H., HEYA, T., and SHIMAMOTO, T., 1989, Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and phamacological effects in animals. Journal of Pharmacy and Phamacology, 41, 439-444.
25. OGAWA, Y., OKADA, H., YAMAMOTO, M., and SHIMAMOTO, T., 1988a, In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic acids) and in vivo degradation of these polymers. Chemical and Pharmaceutical Bulletin, 36, 2576-2581.
26. OGAWA, Y., YAMAMOTO, M., OKADA, H., YASHIKI, T., and SHIMAMOTO, T., 1988b, A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chemical and Pharmaceutical Bulletin, 36, 1095-1103.
27. OGAWA, Y., YAMAMOTO, M., TAKADA, S., OKADA, H., and SHIMAMOTO, T., 1988c, Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic glycolid) acid microcapsules: Influence of molecular weight and copolymer ratio of polymer. Chemical and Pharmaceutical Bulletin, 36, 1502-1507.
28. OKADA, H., HEYA, H., OGAWA, Y., and SHIMAMOTO, T., 1988, One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats. Journal of Pharmacology and Experimental Therapeutics, 244, 744-750.
29. OKADA, H., INOUE, Y., HEYA, T., UENO, H., OGAWA, Y., and TOGUCHI, H., 1991, Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate. Pharmaceutical Research, 8, 787-791.
30. SCHEIN, C. H., 1990, Solubility as a function of protein structure and solvent components. Bio/technology, 8, 308-317.
31. SCHWENDEMAN, S. P., CARDAMONE, M., BRANDON, M. R., KLIBANOV, A., and LANGER, R., 1995a, Stability of proteins and their delivery from biodegradable polymer microspheres. In Microparticulate Systems for the Delivery of Proteins and Vaccines, edited by S. Cohen and H. Bertstein (New York: Marcel Dekker), pp. 1-49.
32. SCHWENDEMAN, S. P., COSTANTINO, H. R., GUPTA, R. K., SIBER, G. R., KLIBANOV, A. M., and LANGER, R., 1995b, Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation. Proceedings of the National Academy of Sciences, USA, 92, 11234-11238.
33. SCHWENDEMAN, S. P., COSTANTINO, H. R., GUPTA, R. K., TOBIO, M., CHANG, A.-C., ALONSO, M. J., SIBER, G. R., and LANGER, R., 1996, Strategies for the stabilization of tetanus toxoid toward the development of a single-dose tetanus vaccine. Developments in Biological Standardization, 87, 293-306.
34. SCHWENDEMAN, S. P., GUPTA, R. K., SIBER, G. R., and LANGER, R., 1995c, Pathways of inactivation of tetanus toxoid in the presence of PLA 2000. Pharmaceutical Research, 12, S-80.
35. SCHWENDEMAN, S. P., LEE, J. H., GUPTA, R. K., COSTANTINO, H. R., SIBER, G. R., and LANGER, R., 1994, Inhibition of moisture-induced aggregation of tetanus toxoid by protecting thiol groups. Proceedings of the International Symposium on Controlled Release of Bioactive Materials, 21, 54-55.
36. SLUZKY, V., KLIBANOV, A. M., and LANGER, R., 1992, Mechanism of insulin aggregation and stabilization in agitated aqueous solutions. Biotechnology and Bioengineering, 40, 895-903.
37. SLUZKY, V., TAMADA, J. A., KLIBANOV, A. M., and LANGER, R., 1991, Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proceedings of the National Academy of Sciences, USA, 88, 9377-9381.
38. TOGUCHI, H., 1990, Pharmaceutical manipulation of leuprolide acetate to improve clinical performance. Journal of International Medical Research, 18 (suppl. 1), 35-41.
39. VOLKIN, D. B., and KLIBANOV, A. M., 1989, Minimizing protein inactivation. In Protein Function: A Practical Approach, edited by T. E. Creighton (Oxford: Oxford University Press), pp. 1-24.
40. VRKLJAN, M., FOSTER, T., POWERS, M., HENKIN, J., PORTER, W., STAACK, H., CARPENTER, J., and MANNING, M., 1994, Thermal stability of low molecular weight urokinase during heat treatment. II. Effect of polymer additives. Pharmaceutical Research, 11, 1004-1008.
41. WADA, R., HYON, S. H., and YKADA, Y., 1990, Lactic acid oligomer microspheres containing hydrophilic drug. Journal of Pharmaceutical Sciences, 78, 919-924.
42. WHO, 1995, Meeting of the Working Group on Single-dose Tetanus Vaccines (World Health Organization Global Programme for Vaccines and Immunization). The Food and Drug Administration, Bethesda, MD.
43. YOUNGS, J. F., 1967, Humidity control in the laboratory using salt solutions - a review. Journal of Applied Chemistry, 17, 241-245.
44. ZAKS, A., and KLIBANOV, A. M., 1988, The effect of water on enzyme action in organic media. Journal of Biological Chemistry, 263, 8017-8021.